Financial Snapshot (Last 12 Months):Market Cap: $306.80M Revenues: $69.50M Net Income: $-3.50M
Alerts: Sign up to get IPO Ratings and Deal Alerts
We are a medical technology company that develops, manufactures and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Traditionally, these patients have relied on stationary oxygen concentrator systems for use in the home and oxygen tanks or cylinders for mobile use, which we call the delivery model. The tanks and cylinders must be delivered regularly and have a finite amount of oxygen, which requires patients to plan activities outside of their homes around delivery schedules and a finite oxygen supply.
comments powered by Disqus